Have $1,000? This Beaten-Down Biotech Has 4 Phase 3 Obesity Trials Underway.
Key PointsViking Therapeutics has four phase 3 obesity trials underway for VK2735.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.